Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × Chemotherapy, Adjuvant × 90 days × Clear all

NCT07450183 2026-03-04

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms